Unpacking the Latest Options Trading Trends in Viking Therapeutics
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
深口袋的投资者对Viking Therapeutics（NASDAQ:VKTX）采取了看淡的态度，这是市场参与者不应忽视的事情。我们在Benzinga的公共期权记录跟踪中发现了这个重要的动向。这些投资者的身份尚不清楚，但VKTX的这样巨大的变动通常意味着即将发生一些重要的事情。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
今天Benzinga的期权扫描仪突出了Viking Therapeutics 的17种非凡期权活动，我们通过今天的观察获得了这些信息。这种活动水平是不寻常的。
The general mood among these heavyweight investors is divided, with 29% leaning bullish and 52% bearish. Among these notable options, 2 are puts, totaling $76,575, and 15 are calls, amounting to $585,344.
这些重量级投资者的心情普遍分为两种，29%看好，52%看淡。在这些值得注意的期权中，有2个是看跌期权，总计76,575美元，还有15个看涨期权，总计585,344美元。
Projected Price Targets
预计价格目标
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $12.0 to $100.0 for Viking Therapeutics over the last 3 months.
考虑到这些合约的成交量和未平仓利息，似乎在过去的三个月中鲸鱼们一直在瞄准Viking Therapeutics的股价区间为12到100美元。
Volume & Open Interest Trends
成交量和未平仓量趋势
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
这些数据可以帮助您跟踪Coinbase Glb期权的流动性和利益，以给定的行权价格为基础。
This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price.
下面，我们可以观察到在Viking Therapeutics 49.0美元至130.0美元行权价位范围内，鲸鱼对看涨期权和看跌期权的成交量和持仓量的演变情况。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale activity within a strike price range from $12.0 to $100.0 in the last 30 days.
下面我们可以看到，在过去30天中，Viking Therapeutics所有的鲸鱼活动中，所有期权的成交量和未平仓利息的演变情况，其中包括了所有在12到100美元的执行价格区间内的看涨期权和看跌期权。
Viking Therapeutics Option Activity Analysis: Last 30 Days
Viking Therapeutics 期权交易分析：过去30天
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 11/15/24 | $19.3 | $18.3 | $18.5 | $50.00 | $62.9K | 299 | 11 |
| VKTX | CALL | SWEEP | BEARISH | 08/30/24 | $3.2 | $2.8 | $2.8 | $70.00 | $54.6K | 245 | 402 |
| VKTX | CALL | TRADE | BEARISH | 01/17/25 | $51.8 | $51.0 | $51.0 | $12.00 | $51.0K | 70 | 10 |
| VKTX | PUT | TRADE | BEARISH | 09/20/24 | $8.3 | $7.2 | $8.3 | $65.00 | $49.8K | 544 | 0 |
| VKTX | CALL | SWEEP | BEARISH | 08/30/24 | $3.2 | $3.0 | $3.0 | $65.00 | $45.0K | 1.5K | 477 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看涨 | 交易 | 看淡 | 11/15/24 | $19.3 | $18.3 | $18.5 | $50.00 | $62.9K | 299 | 11 |
| VKTX | 看涨 | SWEEP | 看淡 | 08/30/2024 | $3.2 | $2.8 | $2.8 | 70.00美元 | $54.6K | 245 | 402 |
| VKTX | 看涨 | 交易 | 看淡 | 01/17/25 | $51.8 | $51.0 | $51.0 | 12.00美元 | $51.0K | 70 | 10 |
| VKTX | 看跌 | 交易 | 看淡 | 09/20/24 | $8.3 | $7.2 | $8.3 | $65.00 | $49.8K | 544 | 0 |
| VKTX | 看涨 | SWEEP | 看淡 | 08/30/2024 | $3.2 | $3.0 | $3.0 | $65.00 | $45.0K | 1.5K | 477 |
About Viking Therapeutics
关于Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家卫生服务提供商，专门从事代谢和内分泌障碍领域的生物制药开发。该公司的临床项目流水线包括VK2809、VK5211、VK0214产品。VK2809和VK0214是口服、组织和受体亚型选择性的甲状腺激素受体β激动剂。VK5211是一种口服、非类固醇选择性雄激素受体调节剂。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析与Viking Therapeutics相关的期权交易活动后，我们转而更近距离地关注该公司的业绩表现。
Viking Therapeutics's Current Market Status
维京治疗公司的当前市场状态
- Currently trading with a volume of 2,237,127, the VKTX's price is down by -5.93%, now at $62.68.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 64 days.
- VKTX当前的成交量为2,237,127，价格下跌了5.93%，现在为62.68美元。
- RSI读数表明该股目前可能接近超买水平。
- 预计即将发布的财报还有64天。
Expert Opinions on Viking Therapeutics
维京治疗公司的专家意见
In the last month, 2 experts released ratings on this stock with an average target price of $104.0.
在过去一个月中，另外两位专家发布了关于这个股票的评级，目标价的平均值为104.0美元。
- An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $90.
- An analyst from Raymond James persists with their Strong Buy rating on Viking Therapeutics, maintaining a target price of $118.
- 来自HC Wainwright & Co.的分析师已将评级调低为买入，调整价格目标为90美元。
- 来自Raymond James的分析师坚持他们对Viking Therapeutics的强烈买入评级，维持目标价为118美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Viking Therapeutics options trades with real-time alerts from Benzinga Pro.
期权交易具有更高的风险和潜在回报。精明的交易者通过不断学习，调整策略，监测多种因子以及密切关注市场走势来管理这些风险。通过Benzinga Pro的实时警报随时了解最新的Viking Therapeutics期权交易。